Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CVS Health suma 74 puntos de vacunación contra la COVID-19 en Texas
  • USA - English

Actualmente, la compañía aplica la vacuna en 180 farmacias de CVS en todo el estado

Los nuevos puntos de vacunación en Texas se encuentran entre los casi 1,200 centros distribuidos en 29 estados donde la compañía aplica la vacuna

CVS Health (PRNewsFoto/CVS Health) (PRNewsFoto/CVS Health)

News provided by

CVS Health

Mar 11, 2021, 20:13 ET

Share this article

Share toX

Share this article

Share toX

WOONSOCKET, Rhode Island, 11 de marzo de 2021 /PRNewswire-HISPANIC PR WIRE/ -- En el marco de un continuo esfuerzo por frenar la propagación del virus y colaborar con la reapertura de las comunidades, CVS Health (NYSE: CVS) anunció hoy que comenzará a aplicar vacunas a poblaciones elegibles desde el domingo 14 de marzo en 74 farmacias adicionales de CVS distribuidas en el estado de Texas. A partir del sábado 13 de marzo se podrá agendar cita para los últimos lotes de vacunas disponibles, a medida que las farmacias reciban los envíos. Los puntos de vacunación adicionales se suman a las 106 sucursales habilitadas previamente en el estado, con lo que el total de farmacias de CVS a cargo de administrar la vacuna en Texas asciende a 180.

Continue Reading
CVS Pharmacy Begins Administering COVID-19 Vaccines. (Scott Eisen/CVS Health via AP Images) (PRNewsfoto/CVS Health)
CVS Pharmacy Begins Administering COVID-19 Vaccines. (Scott Eisen/CVS Health via AP Images) (PRNewsfoto/CVS Health)
CVS Pharmacy Begins Administering COVID-19 Vaccines. (Scott Eisen/CVS Health via AP Images) (PRNewsfoto/CVS Health)
CVS Pharmacy Begins Administering COVID-19 Vaccines. (Scott Eisen/CVS Health via AP Images) (PRNewsfoto/CVS Health)
CVS___HealthHUB
CVS___HealthHUB

"Nos enorgullece ayudar a ampliar el acceso a la vacuna para tantas personas como sea posible con el fin de respaldar las iniciativas de reapertura en las comunidades en las que prestamos servicios", señaló Neela Montgomery, presidente de CVS Pharmacy y vicepresidente ejecutiva de CVS Health. "Los comentarios sobre todos los aspectos del proceso de vacunación han sido de lo más positivos, desde la experiencia digital hasta la interacción con nuestro equipo de profesionales de la salud, cuyos increíbles esfuerzos nos ayudan a acercarnos al eventual final de la pandemia".

Las vacunas de las farmacias CVS participantes en Texas estarán disponibles para las personas que cumplan los criterios de elegibilidad del estado, así como para los maestros y el personal de preescolar hasta grado 12 y los trabajadores de cuidados infantiles. Los pacientes deben registrarse por adelantado en CVS.com o a través de la aplicación CVS Pharmacy. Quienes no cuenten con acceso a internet pueden ponerse en contacto con la línea de Servicio al cliente de CVS llamando al [(800) 746-7287]. No se aplicará la vacuna a las personas que se acerquen al punto de vacunación sin una cita previa.

Los insumos utilizados en el proceso ampliado de vacunación del estado son suministrados directamente por el Programa Federal de Farmacias Minoristas. Las sucursales participantes de CVS Pharmacy se encuentran en los siguientes condados: Anderson, Angelina, Bexar, Brazoria, Cameron, Collin, Dallas, Denton, El Paso, Ellis, Fort Bend, Harris, Hidalgo, Jim Wells, Johnson, Lubbock, McLennan, Montgomery, Smith, Tarrant y Williamson. En la medida en que se disponga de más suministros, la compañía ampliará el acceso a más sucursales en más comunidades de Texas.

Los 180 puntos de Texas forman parte de las casi 1,200 sucursales de CVS Pharmacy en las que la compañía está aplicando la vacuna en Puerto Rico y 28 estados de los Estados Unidos: Alabama, Arizona, California, Carolina del Norte, Carolina del Sur, Colorado, Connecticut, Dakota del Norte, Florida, Hawái, Illinois, Kentucky, Luisiana, Maryland, Massachusetts, Minnesota, Missouri, Montana, Nueva Jersey, Nevada, Nueva York, Ohio, Oklahoma, Pensilvania, Rhode Island, Utah, Vermont y Virginia. Dependiendo de las existencias, las vacunas estarán disponibles en sucursales de CVS Pharmacy de todo el país, y se prevé alcanzar una capacidad de aplicar entre 20 y 25 millones de vacunas al mes.

Aquí encontrará recursos multimedia, incluyendo material de archivo (b-roll) y fotografías de centros de cuidados prolongados y vacunas contra la COVID-19 en tiendas. Hay más información disponible sobre los pasos que CVS Health ha dado para hacer frente a la pandemia en el centro de recursos sobre la COVID-19 de la compañía, el cual se actualiza con frecuencia.

Acerca de CVS Health
CVS Health es un tipo diferente de compañía de cuidado de la salud. Somos una compañía de servicios de salud diversificados con cerca de 300,000 empleados unidos en torno al propósito común de ayudar a las personas en su camino hacia una mejor salud. En un mundo cada vez más conectado y digital, llegamos a las personas en el lugar en que se encuentren y cambiamos los cuidados de la salud para satisfacer sus necesidades. Sobre la base de una presencia sin igual en la comunidad, hemos desarrollado un modelo diversificado con el que interactúa una de cada tres personas en los Estados Unidos cada año. Desde nuestros nuevos e innovadores servicios provistos en los centros HealthHUB®, hasta los programas transformadores que ayudan a controlar afecciones crónicas, hacemos que el cuidado de la salud sea más accesible, más asequible y, sencillamente, mejor. Obtenga más información acerca de cómo estamos transformando la salud en www.cvshealth.com.

Contacto para los medios 
Monica Prinzing, (831) 241-8294
[email protected]

Fotografía: https://mma.prnewswire.com/media/1431689/CVS_Pharmacy_Begins_Administering_COVID_19_Vaccines.jpg
Fotografía: https://mma.prnewswire.com/media/1431688/CVS_Pharmacy_Begins_Administering_COVID_19_Vaccines_2.jpg
Fotografía: https://mma.prnewswire.com/media/1346096/CVS___HealthHUB.jpg
Logotipo: https://mma.prnewswire.com/media/487051/CVS_HealthLogo.jpg

FUENTE CVS Health

Related Links

www.cvshealth.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Omnicare Initiates Voluntary Chapter 11 Process

Omnicare Initiates Voluntary Chapter 11 Process

Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), today announced it has initiated a voluntary court-supervised Chapter 11 process to resolve...

Aetna Expands Clinical Collaboration Program to Enhance Support for Hospitals and Provide Personalized Member Care

Aetna Expands Clinical Collaboration Program to Enhance Support for Hospitals and Provide Personalized Member Care

Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

Retail

Retail

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.